Deep Track Capital
About Deep Track Capital
Deep Track Capital is a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry.
Recent News
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
The Week’s 10 Biggest Funding Rounds: Largest Financings Went To Defense, Wearables, Energy And Security
Terremoto Raises $108M to Pursue Development of Drugs Targeting AKT
Recent Deals
Ambrosia Biosciences Secures $100M Series B Funding
Terremoto Biosciences Raises $108M in Series C Financing Round
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners
Tubulis Raises €308M (USD 361M) in Series C Led by Venrock Healthcare Capital Partners